Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06347874 · ClinicalTrials.gov registry record · Phase 4

Cryo Rib Fracture Study

A Phase 4 study of Rib Fractures, sponsored by University of Minnesota.

Recruiting
Registry status
Phase 4
Development phase
48
Enrollment target
1
Study location

NCT06347874 is a Phase 4 study of Rib Fractures that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 48 participants, below the 96-participant average among 9 other Rib Fractures trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06347874, a Phase 4 study of Rib Fractures, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
Phase 4
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Conditions Studied

Interventions

  • DRUG Cryoablation
  • DRUG ESP Catheter

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2025-01-10
Est. Completion 2027-03-13
Phase Phase 4

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT06347874

The ClinicalTrials.gov registry entry for NCT06347874 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 9 other Rib Fractures trials with a reported enrollment target (50% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rib Fractures appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation is the first listed.

NCT06347874 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06347874 about?

NCT06347874 is a clinical study titled "Cryo Rib Fracture Study". The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

What is the current status of trial NCT06347874?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2025-01-10. Estimated completion is 2027-03-13.

What conditions does trial NCT06347874 study?

This clinical trial studies the following conditions: Rib Fractures.

What interventions are being tested in trial NCT06347874?

The interventions under investigation include: Cryoablation (DRUG), ESP Catheter (DRUG).

Who is sponsoring clinical trial NCT06347874?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06347874 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rib Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.